[1]沈奇伟 邵怡凯 姚琪远.分子生物学在代谢手术治疗肥胖与糖尿病机制中的研究进展[J].中华肥胖与代谢病电子杂志,2016,2(04):196-200.[doi:10.3877/cma.j.issn.2095-9605.2016.04.003]
点击复制

分子生物学在代谢手术治疗肥胖与糖尿病机制中的研究进展()
分享到:

《中华肥胖与代谢病电子杂志》[ISSN:2095-9605/CN:11-9362]

卷:
第2卷
期数:
2016年04期
页码:
196-200
栏目:
专家论坛
出版日期:
2016-12-21

文章信息/Info

作者:
沈奇伟 邵怡凯 姚琪远
200040 上海,复旦大学附属华山医院普外科
关键词:
分子生物学 代谢手术 研究进展
DOI:
10.3877/cma.j.issn.2095-9605.2016.04.003

参考文献/References:

[1] Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013[J]. Lancet, 2014, 384(9945):766-781.
[2] Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030[J]. Diabetes Res Clin Pract, 2010, 87(1):4-14.
[3] Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes[J]. New Engl J Med, 2012, 366(17):1577-1585.
[4] Chang SH, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012[J]. JAMA Surg, 2014, 149(3):275-287.
[5] Chambers AP, Kirchner H, Wilson-Perez HE, et al. The effects of vertical sleeve gastrectomy in rodents are ghrelin independent[J]. Gastroenterology, 2013, 144(1):50-52.
[6] Valderas JP, Irribarra V, Rubio L, et al. Effects of sleeve gastrectomy and medical treatment for obesity on glucagon-like peptide 1 levels and glucose homeostasis in non-diabetic subjects[J]. Obes Surg, 2011, 21(7):902-909.
[7] Peterli R, W?lnerhanssen B, Peters T, et al. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial[J]. Ann Surg, 2009, 250(2):234-241.
[8] Wilson-Pérez HE, Chambers AP, Ryan KK, et al. Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like peptide 1 receptor deficiency[J]. Diabetes, 2013, 62(7):2380-2385.
[9] Ye J, Hao Z, Mumphrey MB, et al. GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents[J]. Am J Physiol Regul Integr Comp Physiol, 2014, 306(5):R352-362.
[10] le Roux CW, Welbourn R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass[J]. Ann Surg, 2007, 246(5):780-785.
[11] Chandarana K, Gelegen C, Karra E, et al. Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY[J]. Diabetes, 2011, 60(3):810-818.
[12] Woelnerhanssen B, Peterli R, Steinert RE, et al. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy--a prospective randomized trial[J]. Surg Obes Relat Dis, 2011, 7(5):561-568.
[13] Kawano Y, Ohta M, Hirashita T, et al. Effects of sleeve gastrectomy on lipid metabolism in an obese diabetic rat model[J]. Obes Surg, 2013, 23(12):1947-1956.
[14] Kelly AS, Ryder JR, Marlatt KL, et al. Changes in inflammation, oxidative stress and adipokines following bariatric surgery among adolescents with severe obesity[J]. Int J Obes (Lond), 2016, 40(2):275-280.
[15] Lima MM, Pareja JC, Alegre SM, et al. Visceral fat resection in humans: effect on insulin sensitivity, beta-cell function, adipokines, and inflammatory markers[J]. Obesity (Silver Spring), 2013, 21(3):E182-E189.
[16] Schneck AS, Iannelli A, Patouraux S, et al. Effects of sleeve gastrectomy in high fat diet-induced obese mice: respective role of reduced caloric intake, white adipose tissue inflammation and changes in adipose tissue and ectopic fat depots[J]. Surg Endosc, 2014, 28(2):592-602.
[17] Hankir MK, Bronisch F, Hintschich C, et al. Differential effects of Roux-en-Y gastric bypass surgery on brown and beige adipose tissue thermogenesis[J]. Metabolism, 2015, 64(10):1240-1249.
[18] Li T, Chiang JY. Bile acid signaling in metabolic disease and drug therapy[J]. Pharmacol Rev, 2014, 66(4):948-983.
[19] Fiorucci S, Distrutti E. Bile acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders[J]. Trends Mol Med, 2015, 21(11):702-714.
[20] Fang S, Suh JM, Reilly SM, et al. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance[J]. Nat Med, 2015, 21(2):159-165.
[21] Ryan KK, Tremaroli V, Clemmensen C, et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy[J]. Nature, 2014, 509(7499):183-188.
[22] Watanabe M, Houten SM, Mataki C, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation[J]. Nature, 2006, 439(7075):484-489.
[23] Thomas C, Gioiello A, Noriega L, et al. TGR5-mediated bile acid sensing controls glucose homeostasis[J]. Cell Metab, 2009, 10(3):167-177.
[24] Pournaras DJ, Glicksman C, Vincent RP, et al. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control[J]. Endocrinology, 2012, 153(8):3613-3619.
[25] Zhao L. The gut microbiota and obesity: from correlation to causality[J]. Nat Rev Microbiol, 2013, 11(9):639-647.
[26] Ridaura VK, Faith JJ, Rey FE, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice[J]. Science, 2013, 341(6150):1241214.
[27] Duca FA, Sakar Y, Lepage P, et al. Replication of obesity and associated signaling pathways through transfer of microbiota from obese-prone rats[J]. Diabetes, 2014, 63(5):1624-1636.
[28] 赵立平 , 费娜 . 肠道菌群与肥胖症的关系研究进展 [J]. 微生物与感染 , 2013, 8(2):67-71.
[29] Carmody RN, Gerber GK, Luevano JM, et al. Diet dominates host genotype in shaping the murine gut microbiota[J]. Cell Host Microbe, 2015, 17(1):72-84.
[30] Furet JP, Kong LC, Tap J, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers[J]. Diabetes, 2010, 59(12):3049-3057.
[31] Liou AP, Paziuk M, Luevano JM, et al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity[J]. Sci Transl Med, 2013, 5(178):178ra41.
[32] Tremaroli V, Karlsson F, Werling M, et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation[J]. Cell Metab, 2015, 22(2):228-238.
[33] Arner P, Kulyté A. MicroRNA regulatory networks in human adipose tissue and obesity[J]. Nat Rev Endocrinol, 2015, 11(5):276-288.
[34] Karbiener M, Scheideler M. MicroRNA functions in brite/Brown fatnovel perspectives towards anti-obesity strategies[J]. Comput Struct Biotechnol J, 2014, 11(19):101-105.
[35] Ono K, Kuwabara Y, Han J. MicroRNAs and cardiovascular diseases[J]. FEBS J, 2011, 278(10):1619-1633.
[36] Wu Q, Li JV, Seyfried F, et al. Metabolic phenotype-microRNA data fusion analysis of the systemic consequences of Roux-en-Y gastric bypass surgery[J]. Int J Obes (Lond), 2015, 39(7):1126-1134.
[37] Lirun K, Sewe M, Yong W. A pilot study: the effect of Roux-en-Y gastric bypass on the Serum microRNAs of the type 2 diabetes patient[J]. Obes Surg, 2015, 25(12):2386-2392.
[38] Brandacher G, Golderer G, Kienzl K, et al. Potential applications of global protein expression analysis (proteomics) in morbid obesity and bariatric surgery[J]. Obes Surg, 2008, 18(7):905-910.
[39] Oberbach A, von Bergen M, Blüher S, et al. Combined serum proteomic and metabonomic profiling after laparoscopic sleeve gastrectomy in children and adolescents[J]. J Laparoendosc Adv Surg Tech A, 2012, 22(2):184-188.

相似文献/References:

[1]褚薛慧 单晓东 邱晨 邓玲 孙喜太.多学科诊疗模式在代谢手术中的应用价值[J].中华肥胖与代谢病电子杂志,2016,2(01):12.[doi:10.3877//cma.j.issn.2095-9605.2016.01.003]
 Chu Xuehui,Shan Xiaodong,Qiu chen,et al.Application value of multidisciplinary treatment mode in metabolic surgery[J].Chinese Journal of Obesity and Metabolic Disease (Electronic Edition),2016,2(04):12.[doi:10.3877//cma.j.issn.2095-9605.2016.01.003]
[2]黄丽 袁翔 陈亿 蒲琳 赖黎 程中 文曰 印义琼.医护一体化在代谢手术围手术期患者心理干预中的应用[J].中华肥胖与代谢病电子杂志,2016,2(03):138.[doi:10.3877//cma.j.issn.2095-9605.2016.03.004]
[3]郭德凯 朱江帆.肥胖症、高尿酸血症和代谢手术相关性的研究进展[J].中华肥胖与代谢病电子杂志,2017,(01):46.[doi:10.3877/cma.j.issn.2095-9605.2017.01.010]
[4]姜永胜 延冰 孙少川.60例代谢手术治疗经验总结[J].中华肥胖与代谢病电子杂志,2017,(01):53.[doi:10.3877/cma.j.issn.2095-9605.2017.01.012]
[5]杜潇 刘航 彭柏强 程扬帆 罗荣 陈亿 程中.减重代谢手术术中不良事件及处理(附视频)[J].中华肥胖与代谢病电子杂志,2017,(03):130.[doi:10.3877/cma.j.issn.2095-9605.2017.03.004 ]
[6]左迪迪 李超 王桂侠 丁明星.代谢手术治疗超重或肥胖短期疗效观察及 减重效果的影响因素分析[J].中华肥胖与代谢病电子杂志,2017,(03):133.[doi:10.3877/cma.j.issn.2095-9605.2017.03.005 ]
 Zuo Didi,Li Chao,Wang Guixia,et al.Analysis of influencing factors for metabolic surgery treating overweight or obesity Short-term efficacy[J].Chinese Journal of Obesity and Metabolic Disease (Electronic Edition),2017,(04):133.[doi:10.3877/cma.j.issn.2095-9605.2017.03.005 ]
[7]王朝阳.舒适护理模式在腹腔镜代谢手术中的应用效果分析[J].中华肥胖与代谢病电子杂志,2017,(03):166.[doi:10.3877/cma.j.issn.2095-9605.2017.03.012 ]
 Wang zhaoyang.Analysis of applied effect of comfortable nursing pattern in laparoscopic metabolic surgery[J].Chinese Journal of Obesity and Metabolic Disease (Electronic Edition),2017,(04):166.[doi:10.3877/cma.j.issn.2095-9605.2017.03.012 ]
[8]魏丹 孟化.BMI < 35 kg/m2 的肥胖症患者行代谢手 术治疗的研究进展[J].中华肥胖与代谢病电子杂志,2018,(03):156.[doi:10.3877/cma.j.issn.2095-9605.2018.03.007]
[9]王福刚 白日星 闫文貌 闫鸣 宋茂民.肠道菌群在代谢手术机制研究中的现状与 展望[J].中华肥胖与代谢病电子杂志,2018,(01):40.[doi:10.3877/cma.j.issn.2095-9605.2018.01.009]
[10]李影 王伟 陈晖 罗娜 刘彦 王艳 赵绮华 孟兆祥 汤东 王道荣 孙晓芳.腹腔镜袖状胃切除术后短期内妊娠 1 例[J].中华肥胖与代谢病电子杂志,2019,(01):46.[doi:DOI:10.3877/cma.j.issn.2095-9605.2019.01.009]

备注/Memo

备注/Memo:
作者简介:姚琪远,主任医师、教授、博士生导师。现任复旦大学附属华山医院微创外科、减重与代谢外科、疝与腹壁外科主任,复旦大学疝病中心主任。兼任上海市医学会普外科专科分会疝与腹壁外科学组副组长、减重与代谢外科学组副组长,中华医学会外科学分会腹腔镜与内镜外科学组委员,中国医师协会外科医师分会肥胖和糖尿病外科医师委员会副主任委员,中国胃食管反流病微创联盟副主席,亚太疝协会执行委员,国际腹壁与造口外科联盟主席。担任《中华疝与腹壁外科杂志》《中华胃食管反流病电子杂志》和《中华肥胖与代谢病电子杂志》副主编。
通讯作者:姚琪远,Email:stevenyao@huashan.org.cn
更新日期/Last Update: 2016-11-30